Distinct sequence patterns characterize the V3 region of HIV Type 1 gp120 from subtypes A and C

AIDS Research and Human Retroviruses

Volumn 22, Issue 7, 2006, Pages 703-708

  Felsövályi, Klára ^a   Nadas, Arthur ^a   Zolla Pazner, Susan ^a   Cardozo, Timothy ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MSB 497A ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120;

ARTICLE; CONSENSUS SEQUENCE; ENVELOPE GENE; GENE; GENE SEQUENCE; GROUP SPECIFIC ANTIGEN GENE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NONHUMAN; PATTERN RECOGNITION; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TARGET CELL; VIRUS CHARACTERIZATION; VIRUS INFECTIVITY;

HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; SEQUENCE ANALYSIS, PROTEIN; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 33745965643     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.703     Document Type: Article

References (11)

1. Chiou SH, Freed EO, Panganiban AT, and Kenealy WR: Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function. AIDS Res Hum Retroviruses 1992;8:1611-1618.
2. Zolla-Pazner S: Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol 2004;4:199-210.
3. Hoffman NG, Seillier-Moiseiwitsch F, Ahn J, Walker JM, and Swanstrom R: Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 2002;76:3852-3864.
4. Louwagie J, Janssens W, Mascola J, et al.: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
5. Leitner T, Foley B, Hahn B, et al.: HIV sequence compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2005, LA-UR 04-7420.
6. Efron B, Halloran E, and Holmes S: Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci USA 1996;93:7085-7090.
7. Korber BT, Farber RM, Wolpert DH, and Lapedes AS: Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: An information theoretic analysis. Proc Natl Acad Sci USA 1993;90:7176-7180.
8. Huang CC, Tang M, Zhang MY, et al: Structure of a V3-containing HIV-1 gp120 core. Science 2005;310:1025-1028.
9. Krachmarov C, Pinter A, Honnen WJ, et al: Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking. J Virol 2005;79:780-790.
10. Zolla-Pazner S, Zhong P, Revesz K, et al: The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1. AIDS Res Hum Retroviruses 2004;20:1254-1258.
11. Gaschen B, Taylor J, Yusim K, et al: Diversity considerations in HIV-1 vaccine selection. Science 2002;296:2354-2360.